Introduction
Materials and methods
Search strategy
Study selection
Identification of eligible studies
Quality assessment
Data abstraction
Data analysis
Results
Selection of studies
Study characteristics
Study | Stated injury onset | Injury onset category | Study design | Blinding | Haemarthrosis | Random order of tests | Index test description | Gender | Age range (average) | Duration Index test to reference standard |
---|---|---|---|---|---|---|---|---|---|---|
Blanke et al. 2020 [6] | 6 weeks after injury | Non-acute | RCT | Examiner blinded to clinical history and group allocation | No data | Yes | Yes | 62 M 38 F | No data (ACL rupture -26.4 Controls—45.4) | No data |
Bomberg et al. 1990 [8] | “acute” | Acute | Prospective | No data | Present – no mention of action | No data | No | 31 M 14 F | 13–42 (21) | No data |
Chong et al. 2017 [9] | After 72 h | Unclear/ both | Retrospective | No data | No data | No | Yes | 21 M 12 F | 11–62 (30.9) | No data |
Cooperman et al. 1990 [11] | > 6 weeks from surgery | Non-acute | Prospective study on retrospectively diagnosed patients | Examiner blinded to patient’s face and torso. Patients wore the type of same shorts | No data | Yes | Yes | 18 M 14 F | 18–57 (26) | At least 6 weeks before the study |
Dahlstedt et al. 1989 [12] | < 22 days | Acute | Retrospective | No data | No data | No data | No | 20 M 21 F | 14–47 (27.5) | No data |
Deveci et al. 2015[18] | 4–25 weeks | Non-acute | Retrospective | No data | No data | No data | Lever test only | 96 M 21 F | 17–45 (25.8) | 4–25 weeks |
Donaldson et al. 1985 [20] | < 19 days | Acute | Retrospective | No data | No data | No data | Lachman only | 62 M 38 F | 15–49 (No data) | Within 19 days |
Fok et al. 2014[22] | > 1 month | Non-acute | Retrospective | No data | No data | No data | No data | 189 M 36 F | 16–52 (26.4) | 1–47 months |
Geraets et al. 2015 [25] | > 5 months | Non-acute | Prospective study on retrospectively diagnosed patients | Blinded to clinical data | No data | Yes | Yes | 41 M 19 F | 19–70 (37) | No data |
Gurpinar et al. 2019 [26] | < 2 weeks | Acute | Retrospective | Not blinded | Drained before examination | No | Yes | 69 M 9F | 17–44 (26.17) | No data |
Jarbo et al. 2017 [33] | < 4 weeks | Unclear/ both | Retrospective | Examiner blinded to clinical history, scans and randomly assigned tester | No data | No | Yes | 58 M 44 F | 15–66 (No data) | No data |
Kostov et al. 2014 [38] | Unclear | Unclear/ both | Retrospective | No data | No data | No data | Yes | 81 M 22 F | 16–58 (29.7) | No data |
Krakowski et al. 2019 [39] | mean 44 months | Non-acute | Retrospective | Not blinded | No data | No data | Yes | 47 M 49 F | No data (45) | 44 months average |
Lee et al. 1988 [41] | “most of our patients are nonacute” | Unclear/ both | Retrospective | No data | No data | No data | Yes | No data | 14–59 (No data) | Arthroscopy within 1–5 weeks after MRI |
Lelli et al. 2016 [42] | Acute – less than 20 days Chronic – 20 days to 4 years | Acute & Non-acute | Prospective | Blinded to MRI scan if available | No data | No data | Lever test only | 281 M 119 F | No data (26.4) | No data |
Lichtenberg et al. 2018 [43] | Acute, subacute and chronic (< 3; 3–11; > 12 weeks) | Unclear/ both | Prospective | Not blinded | No data | No | Yes | 57 M 37 F | No data (34) | No data |
Liu et al. 1995 [44] | Within 7 days | Acute | Retrospective | No data | No data | No data | Lachman only | 27 M 11 F | 16–35 (26) | Surgery within 3 weeks |
Makki et al. 2019 [45] | Unclear | Unclear/ both | Retrospective | No data | If present, joint aspiration performed | N/A – 1 test | No data | 44 M 26 F | 13–52 (28) | No data |
McQuivey et al. 2019 [49] | “acute” | Acute | Prospective | Not blinded to clinical history | No data | N/A – 1 test | Yes | 14 M 7 F | 12–54 (31.2) | No data |
Mulligan et al. 2015 [54] | > 30 weeks | Non-acute | Prospective | Examiner blinded to clinical history, MRI scan but not to the patient’s face | No data | Yes | Yes | 21 M 34 F | 20–64 (40.7) | No data |
Peeler et al. 2010 [57] | From 0 to 2143 days | Unclear/ both | Retrospective | No data | No data | No data | Yes | No data | 18–55 (No data) | “significant time elapsed” |
Sandberg et al. 1986 [62] | Average 7 days after injury | Acute | Retrospective | No data | Joint aspiration performed | No data | ADS & Lachman only | No data | 13–59 (27) | No data |
Thapa et al. 2015 [72] | Unclear | Unclear/ both | Prospective | No data | No data | No data | Lever test only | 50 M 30 F | 21–42 (32) | No data |
Wagemakers et al. 2010 [75] | 9–81 days | Unclear/ both | Prospective | Examiner blinded to MRI and clinical history | No data | No data | Yes | 74 M 60 F | No data (40.2) | Immediate– test after MRI |
Study | Injury onset | Complete or partial | Injury type | Reference standard | Test | Number of patients | TP | TN | FP | FN | SN | SP |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Blanke et al. 2020 [6] | Non-acute | Complete | Isolated ACL | A | Lachman | 100 (200) | 74 | 83 | 17 | 26 | 0.74 | 0.83 |
Non-acute | Complete | Isolated ACL | A | Pivot | 100 (200) | 46 | 96 | 4 | 54 | 0.46 | 0.96 | |
Bomberg et al. 1990 [8] | Acute | Complete | Isolated ACL ± meniscal tear | A | ADS | 21 | 2 | 0 | 0 | 19 | 0.10 | – |
Acute | Complete | Isolated ACL ± meniscal tear | A | Lachman | 21 | 18 | 0 | 0 | 3 | 0.86 | – | |
Acute | Complete | Isolated ACL ± meniscal tear | A | Pivot | 21 | 9 | 0 | 0 | 12 | 0.43 | – | |
Chong et al. 2017 [9] | Unclear/ Both | C & P | Isolated ACL | A | Lachman (physician assistant) | 33 | 22 | 0 | 0 | 11 | 0.67 | – |
Unclear/ Both | C & P | Isolated ACL | A | Lachman (surgeon) | 33 | 31 | 0 | 0 | 2 | 0.94 | – | |
Unclear/ Both | C & P | Isolated ACL | A | Lever (physician assistant) | 33 | 27 | 0 | 0 | 6 | 0.82 | – | |
Unclear/ Both | C & P | Isolated ACL | A | Lever (surgeon) | 33 | 29 | 0 | 0 | 4 | 0.88 | – | |
Unclear/ Both | C & P | Isolated ACL | A | Pivot (physician assistant) | 33 | 3 | 0 | 0 | 30 | 0.09 | – | |
Unclear/ Both | C & P | Isolated ACL | A | Pivot (surgeon) | 33 | 9 | 0 | 0 | 24 | 0.27 | – | |
Cooperman et al. 1990 [11] | Non-acute | Complete | Isolated ACL | A | Lachman (Trial 1) | 32 | 20 | 19 | 19 | 6 | 0.77 | 0.50 |
Non-acute | Complete | Isolated ACL | A | Lachman (Trial 2) | 32 | 22 | 22 | 17 | 4 | 0.85 | 0.56 | |
Dahlstedt et al. 1989 [12] | Acute | Complete | Unclear | A | Lachman | 23 | 23 | 0 | 0 | 0 | 1.00 | – |
Acute | Complete | Unclear | A | Pivot | 23 | 2 | 0 | 0 | 21 | 0.09 | – | |
Deveci et al. 2015 [18] | Unclear/ Both | C & P | Isolated ACL ± meniscal tear | A | ADS | 117 | 70 | 0 | 0 | 47 | 0.60 | – |
Unclear/ Both | C & P | Isolated ACL ± meniscal tear | A | Lachman | 117 | 94 | 0 | 0 | 23 | 0.80 | – | |
Unclear/ Both | C & P | Isolated ACL ± meniscal tear | A | Lever | 117 | 110 | 0 | 0 | 7 | 0.94 | – | |
Unclear/ Both | C & P | Isolated ACL ± meniscal tear | A | Pivot | 117 | 73 | 0 | 0 | 44 | 0.62 | – | |
Donaldson et al. 1985 [20] | Acute | Complete | Isolated ACL ± meniscal tear | A | ADS | 33 | 25 | 0 | 0 | 8 | 0.76 | – |
Acute | Complete | Isolated ACL ± meniscal tear | A | Lachman | 33 | 33 | 0 | 0 | 0 | 1.00 | – | |
Acute | Complete | Isolated ACL ± meniscal tear | A | Pivot | 33 | 14 | 0 | 0 | 19 | 0.42 | – | |
Acute | Complete | Isolated ACL | A | ADS | 37 | 20 | 0 | 0 | 17 | 0.54 | – | |
Acute | Complete | Isolated ACL | A | Lachman | 37 | 36 | 0 | 0 | 1 | 0.97 | – | |
Acute | Complete | Isolated ACL | A | Pivot | 37 | 10 | 0 | 0 | 27 | 0.27 | – | |
Fok et al. 2014 [22] | Non-acute | Partial | Isolated ACL ± meniscal tear | A | Pivot | 6 | 5 | 0 | 0 | 1 | 0.83 | – |
Non-acute | Partial | Isolated ACL ± meniscal tear | A | Lachman | 8 | 6 | 0 | 0 | 2 | 0.75 | – | |
Non-acute | C & P | Isolated ACL ± meniscal tear | A | Pivot | 206 | 204 | 0 | 0 | 2 | 0.99 | – | |
Non-acute | C & P | Isolated ACL ± meniscal tear | A | Lachman | 217 | 205 | 0 | 0 | 12 | 0.94 | – | |
Geraets et al. 2015 [25] | Non-acute | Complete | Isolated ACL | A | Lachman (primary care physician) | 60 | 12 | 26 | 12 | 10 | 0.55 | 0.68 |
Non-acute | Complete | Isolated ACL | A | Lachman (surgeon) | 60 | 12 | 38 | 0 | 10 | 0.55 | 1.00 | |
Gurpinar et al. 2019 [26] | Acute | C & P | Isolated ACL ± meniscal tear | MRI | ADS | 78 | 48 | 11 | 5 | 14 | 0.77 | 0.69 |
Acute | C & P | Isolated ACL ± meniscal tear | MRI | Lachman | 78 | 50 | 10 | 6 | 12 | 0.81 | 0.63 | |
Acute | C & P | Isolated ACL ± meniscal tear | MRI | Lever | 78 | 57 | 15 | 1 | 5 | 0.92 | 0.94 | |
Acute | C & P | Isolated ACL ± meniscal tear | MRI | Pivot | 78 | 32 | 15 | 1 | 30 | 0.52 | 0.94 | |
Jarbo et al. 2017 [33] | Unclear/ Both | Unclear | Unclear | MRI | Lever | 48 | 10 | 32 | 1 | 5 | 0.67 | 0.97 |
Kostov et al. 2014 [38] | Unclear/ Both | C & P | Unclear | A | ADS | 103 | 69 | 30 | 0 | 4 | 0.95 | 1.00 |
Unclear/ Both | C & P | Unclear | A | Lachman | 103 | 67 | 30 | 0 | 6 | 0.92 | 1.00 | |
Unclear/ Both | C & P | Unclear | A | Pivot | 103 | 45 | 29 | 1 | 28 | 0.62 | 0.97 | |
Unclear/ Both | C & P | Unclear | MRI | ADS | 103 | 59 | 28 | 10 | 6 | 0.91 | 0.74 | |
Unclear/ Both | C & P | Unclear | MRI | Lachman | 103 | 58 | 29 | 9 | 7 | 0.89 | 0.76 | |
Unclear/ Both | C & P | Unclear | MRI | Pivot | 103 | 42 | 34 | 4 | 23 | 0.65 | 0.89 | |
Krakowski et al. 2019 [39] | Non-acute | Complete | Isolated ACL ± meniscal tear | A | ADS | 96 | – | – | – | – | 0.69 | 0.93 |
Non-acute | Complete | Isolated ACL ± meniscal tear | A | Lachman | 96 | 27 | 0 | 0 | 5 | 0.84 | 0.92 | |
Non-acute | Complete | Isolated ACL ± meniscal tear | A | Lever | 96 | – | – | – | – | 0.63 | 0.98 | |
Non-acute | Complete | Isolated ACL ± meniscal tear | A | Pivot | 96 | – | – | – | – | 0.43 | 0.98 | |
Lee et al. 1988 [41] | Unclear /Both | Unclear | Isolated ACL ± meniscal tear | A | ADS | 41 | 14 | 23 | 0 | 4 | 0.78 | 1.00 |
Unclear/ Both | Unclear | Isolated ACL ± meniscal tear | A | Lachman | 41 | 16 | 23 | 0 | 2 | 0.89 | 1.00 | |
Unclear/ Both | Unclear | Isolated ACL ± meniscal tear | MRI | ADS | 79 | 18 | 56 | 0 | 5 | 0.78 | 1.00 | |
Unclear/ Both | Unclear | Isolated ACL ± meniscal tear | MRI | Lachman | 79 | 21 | 56 | 0 | 2 | 0.91 | 1.00 | |
Lelli et al. 2016 [42] | Acute | Complete | Isolated ACL | MRI | ADS | 100 | 75 | 0 | 0 | 25 | 0.75 | – |
Acute | Complete | Isolated ACL | MRI | Lachman | 100 | 66 | 0 | 0 | 34 | 0.66 | – | |
Acute | Complete | Isolated ACL | MRI | Lever | 100 | 100 | 0 | 0 | 0 | 1.00 | – | |
Acute | Complete | Isolated ACL | MRI | Pivot | 100 | 23 | 0 | 0 | 77 | 0.23 | – | |
Non-acute | Complete | Isolated ACL | MRI | ADS | 100 | 100 | 0 | 0 | 0 | 1 | – | |
Non-acute | Complete | Isolated ACL | MRI | Lachman | 100 | 100 | 0 | 0 | 0 | 1 | – | |
Non-acute | Complete | Isolated ACL | MRI | Lever | 100 | 100 | 0 | 0 | 0 | 1 | – | |
Non-acute | Complete | Isolated ACL | MRI | Pivot | 100 | 98 | 0 | 0 | 2 | 0.98 | – | |
Acute | Partial | Isolated ACL | MRI | ADS | 100 | 29 | 0 | 0 | 71 | 0.29 | – | |
Acute | Partial | Isolated ACL | MRI | Lachman | 100 | 42 | 0 | 0 | 58 | 0.42 | – | |
Acute | Partial | Isolated ACL | MRI | Lever | 100 | 100 | 0 | 0 | 0 | 1.00 | – | |
Acute | Partial | Isolated ACL | MRI | Pivot | 100 | 11 | 0 | 0 | 89 | 0.11 | – | |
Non-acute | Partial | Isolated ACL | MRI | ADS | 100 | 83 | 0 | 0 | 17 | 0.83 | – | |
Non-acute | Partial | Isolated ACL | MRI | Lachman | 100 | 39 | 0 | 0 | 61 | 0.39 | – | |
Non-acute | Partial | Isolated ACL | MRI | Lever | 100 | 100 | 0 | 0 | 0 | 1 | – | |
Non-acute | Partial | Isolated ACL | MRI | Pivot | 100 | 56 | 0 | 0 | 44 | 0.56 | – | |
Lichtenberg et al. 2018 [43] | Unclear/ Both | C & P | Unclear | A | Pivot | 81 | – | – | – | – | 0.50 | 0.98 |
Unclear/ Both | C & P | Unclear | A | Lever | 87 | – | – | – | – | 0.39 | 1 | |
Unclear/ Both | C & P | Unclear | A | ADS | 91 | – | – | – | – | 0.71 | 0.94 | |
Unclear/ Both | C & P | Unclear | A | Lachman | 93 | – | – | – | – | 0.87 | 0.91 | |
Liu et al. 1995 [44] | Acute | Complete | Unclear | A | ADS | 38 | 23 | 0 | 0 | 15 | 0.61 | – |
Acute | Complete | Unclear | A | Lachman | 38 | 36 | 0 | 0 | 2 | 0.95 | – | |
Acute | Complete | Unclear | A | Pivot | 38 | 27 | 0 | 0 | 11 | 0.71 | – | |
Makki et al. 2019 [45] | Unclear/ Both | C & P | Unclear | MRI | Lachman | 50 | 11 | 28 | 7 | 4 | 0.73 | 0.80 |
McQuivey et al. 2019 [49] | Acute | C & P | Isolated ACL | MRI | Lever | 21 | 3 | 17 | 1 | 0 | 1.00 | 0.94 |
Mulligan et al. 2015 [54] | Non-acute | Unclear | Unclear | A | Lachman | 17 | 14 | 1 | 0 | 2 | 0.88 | 1.00 |
Peeler et al. 2010 [57] | Unclear/ Both | Unclear | Unclear | A | ADS (physician) | unclear | – | – | – | – | 0.33 | – |
Unclear/ Both | Unclear | Unclear | A | ADS (surgeon) | unclear | – | – | – | – | 0.39 | – | |
Unclear/ Both | Unclear | Unclear | A | ADS (therapist) | unclear | – | – | – | – | 0.36 | – | |
Unclear/ Both | Unclear | Unclear | A | Lachman (physician) | unclear | – | – | – | – | 0.53 | – | |
Unclear/ Both | Unclear | Unclear | A | Lachman (surgeon) | unclear | – | – | – | – | 0.86 | – | |
Unclear/ Both | Unclear | Unclear | A | Lachman (therapist) | unclear | – | – | – | – | 0.27 | – | |
Unclear/ Both | Unclear | Unclear | A | Pivot (physician) | unclear | – | – | – | – | 0.15 | – | |
Unclear/ Both | Unclear | Unclear | A | Pivot (surgeon) | unclear | – | – | – | – | 0.63 | – | |
Unclear/ Both | Unclear | Unclear | A | Pivot (therapist) | unclear | – | – | – | – | 0.00 | – | |
Sandberg et al. 1986 [62] | Acute | Unclear | Isolated ACL ± meniscal tear | A | ADS | 92 | 37 | 0 | 0 | 55 | 0.40 | – |
Acute | Unclear | Isolated ACL ± meniscal tear | A | Lachman | 92 | 40 | 0 | 0 | 52 | 0.43 | – | |
Acute | Unclear | Isolated ACL ± meniscal tear | A | Pivot | 92 | 4 | 0 | 0 | 88 | 0.04 | – | |
Thapa et al. 2015 [72] | Unclear/ Both | Unclear | Isolated ACL ± meniscal tear | A | ADS | 80 | 28 | 42 | 3 | 7 | 0.80 | 0.93 |
Unclear/ Both | Unclear | Isolated ACL ± meniscal tear | A | Lachman | 80 | 32 | 43 | 2 | 3 | 0.91 | 0.96 | |
Unclear/ Both | Unclear | Isolated ACL ± meniscal tear | A | Lever | 80 | 30 | 40 | 5 | 5 | 0.86 | 0.89 | |
Unclear/ Both | Unclear | Isolated ACL ± meniscal tear | A | Pivot | 80 | 18 | 45 | 0 | 17 | 0.51 | 1.00 | |
Wagemakers et al. 2010 [75] | Unclear/ Both | Complete | Isolated ACL ± meniscal tear | MRI | ADS | 64 | 15 | 26 | 21 | 2 | 0.88 | 0.55 |
Unclear/ Both | C & P | Isolated ACL ± meniscal tear | MRI | ADS | 64 | 23 | 20 | 16 | 5 | 0.82 | 0.56 |
Meta-analysis
All studies [95% CI] | |||||
---|---|---|---|---|---|
Sn | Sp | LR+ | LR− | AUC | |
Anterior Drawer (UA) | 0.75 [0.61; 0.86] | 0.92 [0.67; 0.99] | 2.4 [1.58; 3.64] | 0.28 [0.20; 0.42] | – |
Anterior Drawer (BA) | 0.83 [0.77; 0.88] | 0.85 [0.64; 0.95] | 6.34 [2.32; 15.30] | 0.20 [0.14; 0.30] | 0.87 |
Lachman (UA) | 0.85 [0.77; 0.91] | 0.93 [0.77; 0.98] | 2.72 [1.97; 3.77] | 0.27 [0.20; 0.36] | – |
Lachman (BA) | 0.81 [0.73; 0.87] | 0.85 [0.73; 0.92] | 5.72 [2.82; 10.80] | 0.24 [0.15; 0.35] | 0.882 |
Lever Sign (UA) | 0.98 [0.88; 1.00] | 0.93 [086; 0.96] | 4.56 [2.79; 7.45] | 0.15 [0.09; 0.26] | – |
Lever Sign (BA) | 0.83 [0.68; 0.92] | 0.91 [0.83; 0.95] | 9.66 [5.01;17.30] | 0.18 [0.09; 0.34] | 0.938 |
Pivot Shift (UA) | 0.48 [0.29; 0.68] | 0.96 [0.92; 0.98] | 1.45 [0.73; 2.87] | 0.52 [0.43; 0.64] | – |
Pivot Shift (BA) | 0.55 [0.47; 0.62] | 0.94 [0.88; 0.97] | 10.70 [5.43; 19.30] | 0.48 [0.40; 0.56] | 0.828 |